Search Within

Hannah Yong Wen

Formats
  1. Meeting Abstract (169)
  2. Journal Article (117)
  3. Review (17)
  4. Correspondence (1)
  5. Miscellaneous (1)
Groups
  1. Department of Pathology and Laboratory Medicine (305)
  2. GSK Faculty (173)
  3. Department of Medicine (140)
  4. Solid Tumor Oncology Division (140)
  5. Breast Medicine Service (138)
  6. Gynecology Disease Management Team (119)

More Groups

People
  1. Edi Brogi (201)
  2. Jorge Reis-Filho (128)
  3. Britta Weigelt (114)
  4. Fresia Pareja Zea (91)
  5. Larry Norton (83)
  6. Dara Ross (50)

More People

Years
  1. 2025 (18)
  2. 2024 (27)
  3. 2023 (21)
  4. 2022 (33)
  5. 2021 (19)
  6. 2020 (40)

More Years

Publications
  1. Laboratory Investigation (70)
  2. Modern Pathology (62)
  3. Cancer Research (23)
  4. npj Breast Cancer (14)
  5. Annals of Surgical Oncology (13)
  6. Breast Cancer Research and Treatment (13)

More Publications

Publishers
  1. Nature Publishing Group (93)
  2. Nature Research (62)
  3. American Association for Cancer Research (29)
  4. Springer (28)
  5. Wiley Blackwell (26)
  6. Elsevier Inc. (17)

More Publishers

Results (305)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Oncotype DX recurrence score in multifocal/multicentric ipsilateral invasive breast carcinomas
    Meeting Abstract

    Grabenstetter, A.; Brogi, E.; Chou, J. F.; Morrow, M.; Dickler, M.; Norton, L.; Wen, H. Y.
    Modern Pathology (2018)

    Fulltext@MSK | Save
  • Targeted next generation sequencing analysis of metaplastic breast carcinoma
    Meeting Abstract

    Jameel, Z.; Brogi, E.; Ross, D.; Weigelt, B.; Reis, J.; Wen, H. Y.
    Modern Pathology (2018)

    Fulltext@MSK | Save
  • Estrogen receptor-negative breast adenomyoepitheliomas are driven by co-occurring HRAS hotspot and PI3K pathway gene mutations: A genetic and functional analysis
    Meeting Abstract

    Geyer, F. C.; Li, A.; Papanastasiou, A. D.; Smith, A.; Selenica, P.; Burke, K. A.; Edelweiss, M.; Wen, H. C.; Piscuoglio, S.; Schultheis, A. M.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save
  • Monosomy 17 in potentially curable HER2-amplified breast cancer: Prognostic and predictive impact
    Journal Article

    Page, D. B.; Wen, H.; Brogi, E.; Dure, D.; Ross, D.; Spinelli, K. J.; Patil, S.; Norton, L.; Hudis, C.; McArthur, H. L.
    Breast Cancer Research and Treatment (2018)

    Fulltext@MSK | Save
  • Breast carcinoma with 21-gene recurrence score lower than 18: Rate of locoregional recurrence in a large series with clinical follow-up
    Journal Article

    Turashvili, G.; Brogi, E.; Morrow, M.; Dickler, M.; Norton, L.; Hudis, C.; Wen, H. Y.
    BMC Cancer (2018)

    Fulltext@MSK | Save
  • Impact of an in situ component on outcome after in-breast tumor recurrence in patients treated with breast-conserving therapy
    Journal Article

    Laird, J.; Lok, B.; Siu, C.; Cahlon, O.; Khan, A. J.; McCormick, B.; Powell, S. N.; Cody, H.; Wen, H. Y.; Ho, A.; more...
    Annals of Surgical Oncology (2018)

    Fulltext@MSK | Save
  • Preliminary results from a single-arm, phase II study assessing the efficacy of pembrolizumab plus radiotherapy in metastatic triple negative breast cancer
    Meeting Abstract

    Ho, A.; Barker, C. A.; Gucalp, A.; Lebron-Zapata, L.; Wen, Y. H.; Phung, A.; Wilgucki, M.; Henrich, M.; Arnold, B.; Patil, S.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • A single-arm, phase ii study assessing the efficacy of pembrolizumab (pembro) plus radiotherapy (RT) in metastatic triple negative breast cancer (mTNBC)
    Meeting Abstract

    McArthur, H. L.; Barker, C. A.; Gucalp, A.; Lebron Zapata, L.; Wen, Y. H.; Phung, A.; Wilgucki, M.; Henrich, M.; Arnold, B. B.; Zhang, Z.; more...
    Annals of Oncology (2017)

    Fulltext@MSK | Save
  • 21-gene recurrence score and locoregional recurrence in lymph node-negative, estrogen receptor-positive breast cancer
    Journal Article

    Turashvili, G.; Chou, J. F.; Brogi, E.; Morrow, M.; Dickler, M.; Norton, L.; Hudis, C.; Wen, H. Y.
    Breast Cancer Research and Treatment (2017)

    Fulltext@MSK | Save
  • Standard pathologic features can be used to identify a subset of estrogen receptor-positive, HER2 negative patients likely to benefit from neoadjuvant chemotherapy
    Journal Article

    Petruolo, O. A.; Pilewskie, M.; Patil, S.; Barrio, A. V.; Stempel, M.; Wen, H. Y.; Morrow, M.
    Annals of Surgical Oncology (2017)

    Fulltext@MSK | Save